Charles Schwab
NMRD

Charles Schwab’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Charles Schwab’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,458
Closed -$111K – 3565
2021
Q1 		$111K Hold
14,458
– – ﹤0.01% 3374
2020
Q4 		$55K Hold
14,458
– – ﹤0.01% 3347
2020
Q3 		$52K Hold
14,458
– – ﹤0.01% 3281
2020
Q2 		$134K Buy
+14,458
New +$103K ﹤0.01% 3222

Other funds holding NMRD

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Charles Schwab's NMRD Position: Q2 2021 in Review

Charles Schwab sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q2 2021, closing a stake of 14,458 shares — an estimated $111K sold.

Charles Schwab first reported a position in NMRD in Q2 2020 and held it in 4 quarters. The position peaked at $134K in Q2 2020. 29 funds tracked by Wall St. Rank hold NMRD as of Q2 2021.

  • Charles Schwab reported no remaining Nemaura Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Charles Schwab sold 14,458 Nemaura Medical, Inc. Common Stock shares in Q2 2021, an estimated $111K.
  • Charles Schwab first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Charles Schwab's Nemaura Medical, Inc. Common Stock position peaked at $134K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q2 2021.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.